Oral DNA / HPV Testing

As you may be aware, the past 10 years have provided much insight into what has come to be called “The Oral / Systemic Connection“.

There does appear to be a link to chronic inflammatory periodontal infections and systemic diseases such as:

  • Heart disease
  • Diabetes
  • Stroke
  • Some forms of cancer and other diseases

The National Institute of Health (NIH) and other research facilities are aggressively pursuing this link as well. For More information regarding the Oral/Systemic Connection, visit the following links online: 

National Institutes of Health
American Dental Association 
Academy of Periodontology 
American Dental Hygienists’ Association 

As we continue to learn more about the severity of periodontal infections and how closely linked they are to your overall health, having detailed information about your genetic susceptibility (MyPerioID® PST®) and the bacteria that are present in our mouth (MyPerioPath®) will be critical in determining your oral and overall general health. 

The OraRisk® HPV Salivary Diagnostic Test 

Human papillomavirus (HPV) is one of the most common virus groups in the world. According to the Centers for Disease Control, at least 20 million people in the United States are infected with HPV and there are approximately 6 million new cases each year.

Oral HPV is a manifestation of the HPV virus in the mouth, and is primarily found in the oropharyngeal complex. Specific types of oral HPV are now considered to be separate and serious risk factor for developing oral cancers. Early detection and identification of the presence or absence of oral HPV is important, as early oral HPV infections do not typically cause any clinical signs or symptoms.

The OraRisk® HPV test is a non-invasive, easy-to-use screening tool to identify the type(s) of oral HPV, a mucosal viral infection that could potentially lead to oral cancer. OraRisk® HPV enables the clinician to establish increased risk for oral cancer and determine appropriate referral and monitoring conditions.

Who should be tested?

  • Patients with traditional risk factors for oral cancer
  • Patients who are sexually active
  • Patients with signs and symptoms of oral cancer
  • Patients with suspicious oral lesions


The MyPerioPath® salivary diagnostic test identifies the type and concentration of specific perio-pathogenic bacteria that are known to cause periodontal disease. MyPerioPath® helps support the clinician with better risk assessment and personalized treatment options for more predictable outcomes.

Who should be tested?

  • Patients presenting with signs and symptoms of a periodontal infection
  • Patients with pockets of 4mm or greater with clinical signs of a periodontal infection
  • Patients presenting chronic periodontal disease who are not responding positively to their current treatment
  • Patients with Type 1 or Type 2 diabetes
  • Patients with a history of cardiovascular disease
  • Patients who use tobacco products
  • Patients who will undergo surgical procedures or radiation treatment
  • Can be used for establishing a “baseline” for any patient who may be at increased risk for periodontal infections
  • Patients who test positive for genetic susceptibility with the MyPerioID® PST® test
  • Women of childbearing age

MyPerioID® PST® 

The MyPerioID® PST® test identifies individual genetic susceptibility to periodontal disease and enables the clinician to establish which patients are at increased risk for more severe periodontal infections due to an exaggerated immune response. 

Who should be tested?

  • Patients with a family history of periodontal disease
  • Patients with compromised immune systems
  • Patients that have received therapy but continue with disease activity
  • Patients that will receive implants and have lost teeth to periodontal disease
  • Adolescent patients

PLEASE CALL US TODAY AT Bala Cynwyd Office Phone Number 610-664-7244 ext 301 or 331 TO SCHEDULE YOUR POSSIBLE LIFE SAVING TESTS.